Consistent with their findings, we confirmed the overexpression of CCL11, CCL13, CCL19, CXCL6, and CXCL13, which can be considered markers of IPF and appear central to the progression of the disease. Here, CCL13 is linked to idiopathic pulmonary fibrosis.